When making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.
David Yoder, PharmD, MBA
Advertisement
Articles by David Yoder, PharmD, MBA
Advertisement
Latest Updated Articles
- Payers' Views on the Heterogeneity of Treatment Effect in Oncology
Published: June 22nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Interview with Sa'ed al-Olimat, PharmD: How Pharmacists are Shaping the Future of Psychedelic Therapy
2
December 2025 Product Updates
3
A Healthy Gut Could Improve Mental Health
4
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
5